von Minckwitz G - Search Results

1

Pathway-oriented concepts in adjuvant and neoadjuvant breast cancer therapy.

von Minckwitz G, Fontanella C. von Minckwitz G, et al. Breast Care (Basel). 2013 Aug;8(4):246-7. doi: 10.1159/000354788. Breast Care (Basel). 2013. PMID: 24415976 Free PMC article. No abstract available.

2

Selecting the neoadjuvant treatment by molecular subtype: how to maximize the benefit?

von Minckwitz G, Fontanella C. von Minckwitz G, et al. Breast. 2013 Aug;22 Suppl 2:S149-51. doi: 10.1016/j.breast.2013.07.028. Breast. 2013. PMID: 24074777 Free article. Review.

3

Perspectives from American Society of Clinical Oncology: translational and clinical research highlights in breast and colorectal cancers.

Fontanella C, Aprile G, Scartozzi M, Lederer B, Cascinu S, von Minckwitz G. Fontanella C, et al. Among authors: von minckwitz g. Future Oncol. 2014 Oct;10(12):1901-6. doi: 10.2217/fon.14.150. Future Oncol. 2014. PMID: 25386808

4

Impact of body mass index on neoadjuvant treatment outcome: a pooled analysis of eight prospective neoadjuvant breast cancer trials.

Fontanella C, Lederer B, Gade S, Vanoppen M, Blohmer JU, Costa SD, Denkert C, Eidtmann H, Gerber B, Hanusch C, Hilfrich J, Huober J, Schneeweiss A, Paepke S, Jackisch C, Mehta K, Nekljudova V, Untch M, Neven P, von Minckwitz G, Loibl S. Fontanella C, et al. Among authors: von minckwitz g. Breast Cancer Res Treat. 2015 Feb;150(1):127-39. doi: 10.1007/s10549-015-3287-5. Epub 2015 Feb 13. Breast Cancer Res Treat. 2015. PMID: 25677740

5

Comprehensive Review on the Surrogate Endpoints of Efficacy Proposed or Hypothesized in the Scientific Community Today.

von Minckwitz G, Fontanella C. von Minckwitz G, et al. J Natl Cancer Inst Monogr. 2015 May;2015(51):29-31. doi: 10.1093/jncimonographs/lgv007. J Natl Cancer Inst Monogr. 2015. PMID: 26063882 Review.

6

Clinical usefulness and relevance of intermediate endpoints for cytotoxic neoadjuvant therapy.

Fontanella C, Loibl S, von Minckwitz G. Fontanella C, et al. Among authors: von minckwitz g. Breast. 2015 Nov;24 Suppl 2:S84-7. doi: 10.1016/j.breast.2015.07.020. Epub 2015 Aug 13. Breast. 2015. PMID: 26279131

7

Does toxicity predict efficacy? Insight into the mechanism of action of lapatinib.

Fontanella C, Lederer B, Nekljudova V, Untch M, von Minckwitz G, Loibl S. Fontanella C, et al. Among authors: von minckwitz g. J Clin Oncol. 2014 Oct 20;32(30):3458-9. doi: 10.1200/JCO.2014.57.0499. Epub 2014 Sep 15. J Clin Oncol. 2014. PMID: 25225430 No abstract available.

8

Side effects of standard adjuvant and neoadjuvant chemotherapy regimens according to age groups in primary breast cancer.

Reinisch M, von Minckwitz G, Harbeck N, Janni W, Kümmel S, Kaufmann M, Elling D, Nekljudova V, Loibl S. Reinisch M, et al. Among authors: von minckwitz g. Breast Care (Basel). 2013 Mar;8(1):60-6. doi: 10.1159/000346834. Breast Care (Basel). 2013. PMID: 24715845 Free PMC article.

9

Neoadjuvant Treatment of Breast Cancer.

Untch M, von Minckwitz G. Untch M, et al. Among authors: von minckwitz g. Breast Care (Basel). 2011 Dec;6(6):417. doi: 10.1159/000335444. Epub 2011 Dec 16. Breast Care (Basel). 2011. PMID: 22419893 Free PMC article. No abstract available.

10

Sorafenib in the Treatment of Early Breast Cancer: Results of the Neoadjuvant Phase II Study - SOFIA.

Loibl S, Rokitta D, Conrad B, Harbeck N, Wüllner M, Warm M, Schwedler K, Gerber B, Schrader I, Eidtmann H, Mehta K, Fuhr U, von Minckwitz G. Loibl S, et al. Among authors: von minckwitz g. Breast Care (Basel). 2014 Jul;9(3):169-74. doi: 10.1159/000363430. Breast Care (Basel). 2014. PMID: 25177258 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

368 results

Search Page

Filters